SE9502893L - Användning av kollagenas - Google Patents

Användning av kollagenas

Info

Publication number
SE9502893L
SE9502893L SE9502893A SE9502893A SE9502893L SE 9502893 L SE9502893 L SE 9502893L SE 9502893 A SE9502893 A SE 9502893A SE 9502893 A SE9502893 A SE 9502893A SE 9502893 L SE9502893 L SE 9502893L
Authority
SE
Sweden
Prior art keywords
collagenase
dupuytren
disease
affected
treated
Prior art date
Application number
SE9502893A
Other languages
Unknown language ( )
English (en)
Other versions
SE9502893D0 (sv
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of SE9502893D0 publication Critical patent/SE9502893D0/sv
Publication of SE9502893L publication Critical patent/SE9502893L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9502893A 1994-08-22 1995-08-21 Användning av kollagenas SE9502893L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,097 US5589171A (en) 1994-08-22 1994-08-22 Treatment of Dupuytren's disease with collagenase

Publications (2)

Publication Number Publication Date
SE9502893D0 SE9502893D0 (sv) 1995-08-21
SE9502893L true SE9502893L (sv) 1996-02-23

Family

ID=23131866

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502893A SE9502893L (sv) 1994-08-22 1995-08-21 Användning av kollagenas

Country Status (7)

Country Link
US (1) US5589171A (sv)
DE (1) DE19530832A1 (sv)
DK (1) DK89395A (sv)
FI (1) FI953915A (sv)
GB (1) GB2292521A (sv)
NO (1) NO953262L (sv)
SE (1) SE9502893L (sv)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
JP4967081B2 (ja) * 2005-01-21 2012-07-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク 癒着性関節包炎の処置方法
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
CA2754461A1 (en) * 2009-03-06 2010-09-10 Halozyme, Inc. Temperature sensitive mutants of matrix metalloprotease 1 and uses thereof
US8702654B2 (en) 2009-03-25 2014-04-22 John M. Agee Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
ES2715204T3 (es) 2010-10-30 2019-06-03 Univ Oxford Innovation Ltd Tratamiento de la enfermedad de Dupuytren
PT2734216T (pt) 2011-07-20 2018-11-07 Mediwound Ltd Extrato proteolítico de bromelina para o tratamento de doenças do tecido conjuntivo
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
HUE046160T2 (hu) 2012-01-12 2020-02-28 Endo Global Ventures Clostridium histolyticum enzim
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
WO2014107745A1 (en) 2013-01-07 2014-07-10 Halozyme, Inc. Metal sensitive mutants of matrix metalloproteases and uses thereof
DK2968484T3 (da) 2013-03-15 2021-02-22 Biospecifics Tech Corporation Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase
KR20170096201A (ko) * 2015-01-06 2017-08-23 임프리미스 파마슈티컬스 인코포레이티드 잔틴 또는 잔틴 유도체의 약제학적 제제
WO2017027867A2 (en) 2015-08-13 2017-02-16 City Of Hope Methods, compositions, and kits for detection of bacterial proteases
JP2020511284A (ja) 2017-03-01 2020-04-16 エンド ベンチャーズ リミテッド セルライトを評価及び処置するための装置及び方法
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
AU2020366008A1 (en) 2019-10-15 2022-06-02 Biospecifics Technologies Corp. Treatment of uterine fibroids using purified collagenase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678158A (en) * 1971-05-11 1972-07-18 Worthington Bio Chem Corp Treatment of herniated intervertebral discs of mammals
SU706090A1 (ru) * 1976-06-08 1979-12-30 Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н.Приорова Способ лечени контрактуры дюпюитрена
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US4485088A (en) * 1982-03-26 1984-11-27 Bio-Products, Inc. Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs
US4645668A (en) * 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
RU2005488C1 (ru) * 1992-06-16 1994-01-15 Российская фармацевтическая компания "Фарма" Средство для лечения болезней соединительной ткани

Also Published As

Publication number Publication date
DK89395A (da) 1996-02-23
NO953262L (no) 1996-02-23
GB9516214D0 (en) 1995-10-11
SE9502893D0 (sv) 1995-08-21
FI953915A0 (sv) 1995-08-21
GB2292521A (en) 1996-02-28
FI953915A (sv) 1996-02-23
US5589171A (en) 1996-12-31
DE19530832A1 (de) 1996-02-29
NO953262D0 (no) 1995-08-18

Similar Documents

Publication Publication Date Title
SE9502893D0 (sv) Användning av kollagenas
EP0786995A4 (sv)
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
DK0842169T3 (da) Benzothiophenforbindelser
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
NO940190L (no) Anvendelse av alpha-ketoglutarat
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
NO924694D0 (no) 1-piperidinylalkanoylarylsulfonamidderivater
DE69917445D1 (de) Reinigung von carboxaldehyd
TR199600434A1 (tr) Ikame edilmis 8-klorokinolin'lerin ikame edilmis 8-hidrosikinolin'lere cevrilmesi.
FR2707165B1 (fr) Application des taxoides au traitement de maladies d'origine parasitaire .
FR2691359B1 (fr) Nouvelle application therapeutique du malate de 1-citrulline.
MX9300601A (es) Compuestos de arilalcoxifenoxi-imidazolina.
FI964219A (sv) Filtbehandling - förebyggande av oorganisk lagring medelst spraybehanding
ITPG950031U1 (it) Manico per cappuccio di siringa
IT1255639B (it) Uso dell'oxatomide come agente antitosse
UA1033S (uk) Міні-пальто хутрове жіноче
UA994S (uk) Міні-пальто хутрове жіноче
UA1189S (uk) Міні-пальто жіноче хутрове
UA1185S (uk) Міні-пальто жіноче хутрове
UA1034S (uk) Міні-пальто хутрове жіноче
UA1032S (uk) Міні-пальто хутрове жіноче
SU1277584A1 (ru) 1,1-Ди-[2-(2-фурил)4-оксохиназолинил-3]-этилиден, проявляющий противовоспалительную и анальгезирующую активность

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9502893-2

Format of ref document f/p: F